Glimepiride is a medicine for type 2 diabetes. It is a pill taken once a day, usually with breakfast. It works by helping the pancreas make more insulin, which lowers blood sugar.
Every report comes from a Lived member, sent anonymously.
Have you tried Glimepiride for Type 2 Diabetes?
Glimepiride is a prescription tablet that lowers blood sugar in adults with type 2 diabetes, used alongside changes in eating and physical activity. It belongs to an older class of diabetes medicines called sulfonylureas. It was first sold in the US under the brand name Amaryl, which is no longer marketed there; today it is available as an inexpensive generic. It can be taken on its own or added to other diabetes medicines such as metformin. Glimepiride lowers blood sugar effectively and at low cost, which is why US diabetes guidelines list sulfonylureas among the options to consider when medication cost is a barrier. The trade-offs are a higher chance of low blood sugar and some weight gain. It also lacks the added heart and kidney protection that some newer medicines offer, such as semaglutide (Ozempic), a weekly injection that mimics the gut hormone GLP-1, and empagliflozin (Jardiance), a pill from the newer SGLT2 inhibitor class. It is not used for type 1 diabetes or for diabetic ketoacidosis, a dangerous buildup of acids in the blood, because it only works when the pancreas can still make insulin.
In type 2 diabetes, the body responds poorly to insulin, the hormone that moves sugar from the blood into cells, and the pancreas often cannot make enough extra insulin to make up the difference. Glimepiride acts on the beta cells of the pancreas, the cells that produce insulin. It attaches to a receptor on these cells and closes a potassium channel in their surface, a change that prompts the cells to release insulin. The extra insulin moves more sugar out of the bloodstream, lowering blood sugar levels. Because glimepiride raises insulin levels whether or not a meal follows, it can push blood sugar too low. This is more likely when meals are skipped or small, after hard or prolonged exercise, or after drinking alcohol.
Glimepiride comes as 1 mg, 2 mg and 4 mg tablets taken once a day with breakfast or the first main meal of the day. Prescribers usually start with 1 or 2 mg and raise the dose step by step, no more often than every one to two weeks, based on blood sugar results. The highest recommended dose is 8 mg a day. Older adults and people with reduced kidney function usually start at 1 mg and increase more slowly, because they are more prone to low blood sugar. Taking the dose with a regular meal matters, since taking it and then skipping that meal raises the chance of a low. People who also take colesevelam, a cholesterol-lowering medicine that is sometimes used in diabetes, should take glimepiride at least four hours earlier, because colesevelam reduces how much glimepiride the body absorbs.
Low blood sugar, also called hypoglycemia, is the most important side effect. In one 22-week trial, about 1 in 5 people taking glimepiride had at least one possible episode, compared with about 3 in 100 taking a placebo, and all were managed at home. Typical signs are shakiness, sweating, hunger, a fast heartbeat, dizziness, headache, irritability and confusion. Low blood sugar can also slow thinking and reaction time, which matters for driving. Older adults, people with nerve damage from diabetes, and people taking beta-blockers may notice fewer early warning signs. With symptoms or a reading under 70 mg/dL, take 15 to 20 grams of fast-acting sugar, such as four glucose tablets or half a cup of regular fruit juice, recheck after 15 minutes, and repeat if still low; then have a snack or meal if the next meal is more than an hour away. Lows that keep happening should be reported to the prescriber, since the dose may need to change. If a person passes out, has a seizure or cannot safely swallow, someone nearby should give glucagon (an emergency medicine that raises blood sugar, given as a nasal spray or injection) if it is available and call 911. Other common effects include weight gain (in a 14-week trial, about 2 to 3 kilograms, or roughly 4 to 7 pounds, more than with placebo), dizziness, headache, nausea and weakness. Serious allergic reactions are rare; swelling of the face, lips or throat, trouble breathing, or a blistering or peeling rash needs emergency care. Yellowing of the skin or eyes can signal a rare liver problem and should be reported to the prescriber right away.
Glimepiride should not be taken by anyone who has had an allergic reaction to it or to sulfonamide (sulfa) medicines, because a cross-reaction can occur. People with G6PD deficiency, an inherited enzyme condition that makes red blood cells more fragile, are at higher risk of hemolytic anemia (the breakdown of red blood cells) and may be better served by a different diabetes medicine. Many medicines shift glimepiride's effect. Combining it with insulin or other diabetes medicines adds to the chance of lows, so the glimepiride dose is often lowered when another one is added. The antifungal medicines fluconazole and oral miconazole can raise glimepiride levels and cause severe low blood sugar, while rifampin, an antibiotic used for tuberculosis, can weaken it. Corticosteroids such as prednisone, thiazide water pills and some antipsychotic medicines can raise blood sugar. Beta-blockers, used for blood pressure and heart conditions, can mute the shakiness and racing heartbeat that usually signal a low. Alcohol can lower or raise blood sugar unpredictably. It helps to check with the prescriber or pharmacist before starting or stopping any medicine, including over-the-counter ones. Glimepiride crosses the placenta and can cause low blood sugar in a newborn, so it is stopped at least two weeks before the expected delivery date. Anyone who is pregnant or planning a pregnancy should tell the prescriber. Breastfed babies of parents taking glimepiride should be watched for signs of low blood sugar, such as jitteriness, poor feeding or unusual sleepiness.
Because the dose is adjusted every one to two weeks based on blood sugar readings, people usually see changes in their home readings over the first several weeks. The fuller picture comes from the A1C, a blood test that reflects average blood sugar over about the past three months; many people aim for below 7%, though the right goal varies. In placebo-controlled trials, glimepiride lowered A1C by roughly 1.2 to 1.8 percentage points. Home blood sugar checks are most useful at the start, after a dose change, and during illness or periods of eating less, when lows are more likely. Over time, the care team reviews A1C, kidney function, weight and how often lows occur. Guidelines recommend lowering the dose or switching to a medicine with less risk of lows for people at high risk of hypoglycemia, such as some older adults or people with kidney disease, and many people later add or move to a medicine with heart or kidney benefits. Any change or stop should be planned with the prescriber, because blood sugar control depends on continuing some form of treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Glimepiride, what you've noticed, or ask the community a question.